REVA Medical gibt erfolgreiche Live-Vorführung eines MOTIV®-Eingriffs und neue Ergebnisse der BTK-Studie auf der VIVA26 bekannt

ConferencepositiveMOTIVPositive

AI Analysis

Summary

REVA Medical presented a successful live MOTIV vascular scaffold procedure and new BTK study results at VIVA26 conference, showing higher efficacy rates compared to balloon angioplasty in treating below-knee chronic limb-threatening ischemia in Rutherford 4 and 5 patient groups.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Live procedure demonstrated successful below-knee revascularization with MOTIV vascular scaffolds; BTK study analysis showed higher efficacy rates with MOTIV versus balloon angioplasty in both Rutherford 4 and Rutherford 5 CLTI patient groups

Importance:6/10

Sentiment:

0.75

MOTIVvascular_scaffoldbelow-knee_revascularizationCLTIBTK_studyVIVA26_conferenceballoon_angioplasty_comparison

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on October 6, 2026 10:29 PM

Read Original